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Following infection with Plasmodium falciparum malaria, children in endemic areas develop antibodies speciﬁc to antigens on the par-
asite-infected red cell surface of the infecting isolate, antibodies associated with protection against subsequent infection with that isolate.
In some circumstances induction of antibodies to heterologous parasite isolates also occurs and this has been suggested as evidence for
cross-reactivity of responses against the erythrocyte surface. The role of these relatively cross-reactive antibodies in protection from clin-
ical malaria is currently unknown. We studied the incidence of clinical malaria amongst children living on the coast of Kenya through
one high transmission season. By categorising individuals according to their pre-season parasite status and antibody response to the sur-
face of erythrocytes infected with four parasite isolates we were able to identify a group of children, those who failed to make a concom-
itant antibody response in the presence of an asymptomatic parasitaemia, at increased susceptibility to clinical malaria in the subsequent
6 months. The fact that this susceptible group was identiﬁed regardless of the parasite isolate tested infers a cross-reactive or conserved
target is present on the surface of infected erythrocytes. Identiﬁcation of this target will signiﬁcantly aid understanding of naturally
acquired immunity to clinical malaria amongst children in endemic areas.
 2008 Australian Society for Parasitology Inc. Published by Elsevier Ltd.
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Non-sterile immunity to Plasmodium falciparum
malaria is acquired by individuals living in endemic
areas, enabling them to maintain infections without the
associated morbidity and mortality experienced by non-
immune individuals. Evidence from the passive transfer
of antibodies from immune to non-immune individuals
suggests this immunity is, at least in part, antibody med-0020-7519  2008 Australian Society for Parasitology Inc. Published by Elsev
doi:10.1016/j.ijpara.2008.03.009
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E-mail address: c.mackintosh@talk21.com (C.L. Mackintosh).iated (Cohen et al., 1961; Edozien et al., 1962). Humans
exposed to malaria mount antibody responses to a wide
range of parasite antigens, the majority of which are
unlikely to be associated with protective immunity. The
antibody response to variant parasite antigens expressed
on the surface of the infected erythrocyte (VSA) have,
however, been associated with protection and are speciﬁc
to the infecting isolate following any single episode
(Marsh et al., 1989; Bull et al., 1998; Giha et al., 2000;
Chattopadhyay et al., 2003). Among children exposed
to multiple infections, it has been proposed that clinical
malaria may be, in part, a consequence of gaps in their
anti-VSA antibody repertoire (Bull et al., 1998).ier Ltd. Open access under CC BY license. 
Table 1
Characteristics of individuals tested against Plasmodium falciparum isolate
A4U
Age (years) Total
0–1 2–3 4–5 6–7 8–10
Parasite-positive 9 20 28 21 39 117
Parasite-negative 34 36 28 36 21 155
Total 43 56 56 57 60 272
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infected red cell surface of parasite isolates apparently not
involved in that episode (heterologousparasites)hasbeen sug-
gested as evidence for some cross-reactivity in these responses
(Giha et al., 1998; Chattopadhyay et al., 2003). However, the
role of suchheterologous responses in protection fromclinical
malaria is not clear. Studies from disparate regions across
Africa measuring responses against locally obtained clinical
isolates, isolates taken from individuals resident in geograph-
ically distinct regions and various laboratory reference lines
have yielded conﬂicting results, suggesting that antibody
responses to some parasites but not others are associatedwith
future protection from clinical malaria (Marsh et al., 1989;
Bull et al., 1998, 2002; Giha et al., 2000; Dodoo et al., 2001).
In none of these studies, however, was parasite status at the
time of serum collection taken into account.
Several studies have demonstrated an association
between P. falciparum infection and enhanced anti-erythro-
cyte surface antibody responses to a range of isolates (Iqbal
et al., 1993;Giha et al.,1999a,b;Ofori et al., 2002). In support
of this, more recent data from our group demonstrated that
the proportion of isolates recognised was strikingly higher
amongst childrenwith amicroscopically detectable parasita-
emia at the time of assay compared with those without and
that this associationwas not just due to cumulative exposure.
Rather, it suggests that the presence of parasites reveals
short-lived, more cross-reactive responses (Bull et al., 2002;
Kinyanjui et al., 2004b). The presence of parasites at the time
of serum collection not only leads to increased antibody rec-
ognition but also modiﬁes the likelihood that this measured
response will be associated with protection from both severe
and mild clinical malaria (Bull et al., 2002; Kinyanjui et al.,
2004b; Polley et al., 2004; Osier et al., 2007). The precise tar-
get on the infected erythrocyte surface for these short-lived
responses is currently unknown.
Using a longitudinal study design, we have examined the
relationship between antibodies to antigens on the surface
of erythrocytes infected with P. falciparum and subsequent
protection from mild clinical malaria. We have compared
responses to three laboratory parasite lines, including two dif-
ferent phenotypes of the same isolate, with responses to a
locally acquired clinical isolate, andby factoring into the anal-
ysis the interplay between antibody responses and the pres-
ence of parasites, we demonstrate that failure to mount an
antibody response to the surface of the erythrocyte infected
with any isolate tested predicts subsequent susceptibility to
malaria amongst asymptomatically parasitised children. We
also observe a strong correlation in individual antibody
responses to eachparasite tested, suggesting amore conserved
target on the infected erythrocyte surface for these responses.
2. Materials and methods
2.1. Study population
This work was carried out at the Kenya Medical
Research Institute (KEMRI) Centre for Geographic Med-icine Research Coast (CGMRC) situated at Kiliﬁ District
Hospital, 50 km north of Mombasa on the coast of Kenya.
The hospital serves approximately 240,000 people. Individ-
uals investigated during these immuno-epidemiological
studies were resident in Kiliﬁ District, in an area called
Chonyi. This study site has been described in detail else-
where (Mwangi et al., 2005). Inhabitants of this area are
predominantly Mijikenda. Residents of Chonyi have an
estimated 50 bites/person/year (Mbogo et al., 2003). The
overall annual incidence of clinical malaria has been
reported as 0.55 episodes/person/year (Mwangi et al.,
2005).2.2. Sample collection
Sera collection and active surveillance were conducted
as part of a study examining the clinical epidemiology of
malaria under diﬀering transmission conditions (Mwangi
et al., 2005). In brief, after informed consent was obtained
from parents or guardians, serum was collected in October
2000 from 272 children aged between 6 months and 10
years (Table 1). A blood slide was prepared for every indi-
vidual in the cohort at the time of serum collection in order
to deﬁne their pre-clinical surveillance status as parasite-
positive or -negative and the cohort was followed for evi-
dence of malaria by weekly active surveillance for fever.
Malaria was deﬁned as a febrile episode when individuals
presented with an axillary temperature greater than
37.5 C and a parasitaemia greater than 2500 parasites/ll
above 1 year of age, and fever plus any parasitaemia below
1 year of age. These have been determined to be sensitive
and speciﬁc malaria case deﬁnitions in this study commu-
nity (Mwangi et al., 2005). Twenty non-malaria exposed
control sera were collected from Oxford, United Kingdom.
Sera from a further cohort of children were analysed in
order to examine antibody responses to a heterologous iso-
late in a known susceptible group of children. This cohort
was recruited as part of an investigation into the kinetics of
the antibody response to acute malaria (Kinyanjui et al.,
2003). In brief, sera from 39 children with a mean age of
29.5 months (95% Conﬁdence Interval (CI) 20.3–38.7) res-
ident in Kiliﬁ District were collected at presentation to
Kiliﬁ District Hospital with a primary diagnosis of P. fal-
ciparum malaria. Children were followed up at 1, 2, 3
and 6 weeks after treatment and further serum samples
obtained. The precise details of recruitment and sampling
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al., 2003).2.3. Parasites
Initially, antibody responses were measured to a labora-
tory clone of parasite, A4. This particular parasite was cho-
sen for a number of reasons. There exists a monoclonal
antibody, BC6, which allows in vitro selection of A4 para-
sites speciﬁcally expressing A4 PfEMP1(Roberts et al.,
1992). A4 PfEMP1 has a well-described and classiﬁed
sequence already published with established domain
boundaries and it displays a common cytoadherent pheno-
type, binding to both CD36 and ICAM-1 (Smith et al.,
2000). The parasite clone A4 having undergone prior selec-
tion with BC6 is denoted A4U.
Sera from 140 individuals randomly selected from the
initial cohort of 272 were subsequently tested for recogni-
tion of two further laboratory clones of parasite, A4 40-
cycle (parasites of the A4 lineage which have been left in
culture for 40 cycles with no selection, thus expressing on
the erythrocyte surface a more heterogeneous group of
var genes), 3D7 and one clinical isolate, P1, obtained from
a 5-year-old child admitted to Kiliﬁ District Hospital with
moderately severe malaria (Table 2).
Sera from the cohort of children recruited on presenta-
tion to hospital were tested for recognition of A4U at pre-
sentation and subsequently at each follow-up time point.2.4. Flow cytometry
Using parasite clones A4U, A4 40-cycle, 3D7 and the
clinical isolate, denoted P1, cryo-preserved trophozoite-
infected erythrocytes at between 1% and 5% parasitaemia
were thawed through the sequential restoration of isotonic-
ity (Kinyanjui et al., 2004a). They were washed twice in
RPMI and the pellet was resuspended at 1% haematocrit
in 0.1% BSA/PBS. One microlitre of human serum was
pipetted into separate wells of a 96-well U-bottomed plate
(Nunc Technology) and 9 ll of the infected erythrocyte cell
suspension was added to each well, giving a ﬁnal test serum
concentration of 1:10. The reaction mixture was incubated
at room temperature for 1 h, following which the cells were
spin washed three times with 0.1% BSA/PBS. The cells
were then resuspended in 25 ll of 0.1% BSA/PBS contain-
ing the secondary antibody, rabbit anti-human IgG at aTable 2
Randomly selected sub-group of individuals from within original cohort
(Table 1) tested against two further Plasmodium falciparum parasite lines
and one clinical isolate
Age (years) Total
0–1 2–3 4–5 6–7 8–10
Parasite-positive 7 10 13 11 14 55
Parasite-negative 19 27 23 8 8 85
Total 26 37 36 19 22 140concentration of 1:100. Again the reaction mixture was
incubated for 1 h at room temperature after which a fur-
ther three washes were performed as before. Finally 25 ll
of 0.1% BSA/PBS containing a 1:100 dilution of swine
anti-rabbit IgG coupled to FITC and 10 lg/ml of ethidium
bromide was added to each well. A further incubation at
room temperature in darkness for 1 h was done after
which, following a further series of washes, at least 1000
infected erythrocytes were counted on an EPIC/XL ﬂow
cytometer (Coulter-Electronics, UK).
Reactivity against the infected erythrocyte surface was
scored as mean ﬂuorescent intensity using the method of
Williams and Newbold (2003). In detail, mean ﬂuorescence
of parasite-infected erythrocytes was determined using the
formula:
ðd cÞ  ðb aÞ
a = the mean ﬂuorescence intensity (MFI) of uninfected
erythrocytes following incubation in negative control plas-
ma; b =MFI of parasitised erythrocytes following incuba-
tion in negative control plasma; c =MFI of uninfected
cells incubated in immune plasma or test antibody and
d =MFI of parasitised erythrocytes incubated in immune
plasma or test antibody.
2.5. ELISA
Plasmodium falciparum (A4 strain) schizont extract was
coated onto wells in PBS according to the methods
described by Ndungu et al. (2002). Plates were incubated
overnight at 4 C, after which wells were washed four times
in PBS/Tween (PBS/0.05% Tween 20), and blocked for 5 h
at room temperature with 1% skimmed milk in PBS/Tween
(blocking buﬀer). Wells were washed again and incubated
overnight at 4 C with 100 ll of test sera (1/1 000 dilution
in blocking buﬀer). Plates were then washed four times and
incubated for 3 h at room temperature with 100 ll of
horseradish peroxidase (HRP)-conjugated rabbit anti-
human IgG (Dako Ltd., Buckinghamshire, UK) at 1/5
000 dilution in blocking buﬀer before ﬁnal washing and
detection with H2O2 and O-phenylenediamine (Sigma, St.
Louis, MO, USA). The reaction was stopped with 25 ll
of 2 M H2SO4 per well and absorbance read at 492 nm.
2.6. Statistical analysis
All statistical analysis was performed using Stata8TM
(StataCorp. CA, USA). The relationship between the pres-
ence of parasites and reactivity to the surface of erythro-
cytes infected with each isolate was assessed using logistic
regression. The outcome in every case was positivity for
recognition of each isolate as classiﬁed using the cut-oﬀ
of the mean response from 20 non-exposed donors plus 3
SD Initially the data were explored for additional factors
aﬀecting the likelihood of recognising each isolate. In every
case these were identiﬁed as age (in categories of 6 months
duration) and previous exposure to malaria infection (esti-
Fig. 1. Responses to Plasmodium falciparum isolate A4U. The proportion
of individuals in each age category is shown, with upper 95% conﬁdence
interval, scoring positive for antibody recognition of parasite line A4U.
Positivity was scored as deﬁned in the text. The dark grey bars represent
individuals with no microscopically detectable parasitaemia at the time of
the cross-sectional survey and the light grey bars represent individuals
with parasites detected at that time.
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as a continuous variable). The likelihood of recognition
of each isolate was then compared between those individu-
als who were parasite-positive and those who were para-
site-negative at the time of the cross-sectional survey
when the plasma samples were drawn.
To explore the relationship between antibody responses,
the presence of microscopically detectable parasites at the
time of serum collection and subsequent clinical malaria,
a multiple logistic model was performed after identiﬁcation
of signiﬁcant confounding variables. These were identiﬁed
as age (categorised as a factor of 6 months duration),
and exposure (estimated from responses to whole schizont
extract). The outcome variable was at least one episode of
malaria as deﬁned previously after censoring the ﬁrst 30
days of follow-up (to take account of the possibility that
the child was in fact experiencing an early or partially trea-
ted episode of clinical malaria despite being asymptomatic
at the time of cross-sectional sampling). Individuals were
categorised according to whether or not they had detect-
able parasitaemia at cross-sectional survey and whether
they were positive or negative for recognition of each iso-
late. This variable was then factorised and analysed as
the main explanatory variable in a multiple logistic
regression.
When investigating the likelihood of having a greater
number of episodes of clinical malaria, an ordered logistic
regression was used. Individuals were scored 0, 1, 2, 3 or 4
according to the number of episodes of malaria they suf-
fered during the 6 month follow-up; the resultant odds
ratio (OR) gives the likelihood of being in a higher num-
bered group (i.e. having two episodes compared with one,
three compared with two, etc.,) depending on which struc-
tured antibody/parasite group the individual fell into.
Again confounding variables of age and exposure were
included and the ﬁrst 30 days of follow-up were censored.
Where diﬀerences between two continuous variables
were assessed, no assumptions of distribution were made
and the Wilcoxon rank sum test was used to calculate sig-
niﬁcance. Where more than two variables were compared,
the Kruskal Wallis test was used. All correlations were per-
formed using Spearman’s rank correlation coeﬃcient.
Kaplan–Meier survival curves were plotted using time in
days to ﬁrst episode as previously deﬁned. Throughout the
analysis, P values less than 0.05 were considered
signiﬁcant.
3. Results
3.1. Naturally acquired antibody responses to the surface of
P. falciparum-infected erythrocytes are associated with
increasing age and asymptomatic parasitaemia
Antibody responses to A4U increased signiﬁcantly with
age in individuals who were parasite-positive or parasite-
negative at cross-sectional survey (Fig. 1). Responses
increased similarly with age for the other parasite isolatesused in this study (data not shown, see Supplementary
Fig. S1 for details).
However, in those individuals who were parasite-posi-
tive at the time of sampling, there was a signiﬁcantly
increased likelihood of recognition of all three laboratory
parasite lines and the clinical isolate P1 (A4U OR of recog-
nition if parasite-positive compared with parasite-negative
2.53 (95% CI 1.41–4.54) P = 0.002; A4 40-cycle OR 5.05
(95% CI 2.00–12.75), P = 0.001; 3D7 OR 4.62 (95% CI
1.92–11.12) P = 0.001; P1 OR 2.62 (95% CI 1.01–6.83)
P = 0.049).3.2. Asymptomatic parasitaemia and risk of clinical malaria
Parasite prevalence at cross-section among children
aged 1–10 years in Chonyi was 43.2%. Overall the OR
for an individual developing clinical malaria in the 6
months following the cross-sectional survey if they were
parasite-positive compared with parasite-negative was
3.42 (95% CI 1.81–6.48; P < 0.0001). Limiting the analysis
to risks of a clinical attack 30 days after the initial cross-
section continued to demonstrate a signiﬁcant increased
likelihood of becoming a case if parasite-positive (OR
2.52 (95% CI 1.21–5.27; P = 0.013)).3.3. Association of antibodies to the intact infected-
erythrocyte surface and protection from clinical malaria
As a result of the interaction between parasite status and
antibody recognition of each isolate, all individuals were
categorised into four groups according to both their pre-
season antibody status (positive or negative) and whether
or not they had a microscopically detectable parasitaemia.
Kaplan–Meier survival curves were drawn with each of the
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is clear that for responses against three of the parasite iso-
lates tested, those individuals with asymptomatic parasite
carriage and no concomitant antibody response appeared
to be highly susceptible to mild clinical malaria (Fig. 2).
The likelihood of acquiring at least one episode of clin-
ical malaria in the subsequent 6 months was investigated
according to group in a multiple logistic model with age
and exposure as confounding variables and excluding the
ﬁrst 30 days of follow-up. Table 3 shows the results for
responses to all parasites. It is clear that those children with
asymptomatic parasitaemia at cross-sectional survey with
no concomitant antibody response to A4U had a signiﬁ-
cantly increased risk of experiencing at least one episode
of clinical malaria in the subsequent 6 months
(OR = 3.78 (1.21–11.8), P = 0.022). The same group was
observed to be similarly susceptible when responses to
the other three parasite isolates were considered.
When the outcome examined was the total number of
malaria episodes experienced by each individual over the
follow-up period, an ordered logistic regression model
was used with the same confounding variables included
and the ﬁrst 30 days of follow-up excluded. Again the
group of children who were antibody-negative and para-
site-positive were signiﬁcantly more likely to experience a
greater number of malaria episodes in the subsequent 6
months. This was true for all parasite lines tested (Supple-
mentary Table S1).
In order to examine antibody responses in a known sus-
ceptible group of children, sera from children presenting to
hospital with acute malaria were tested for recognition of
A4U. Sera were collected at each follow-up visit and again
tested for recognition of the surface of unﬁxed A4U. As
can be seen in Fig. 3, children presenting with symptomatic
malaria showed no recognition of this highly selected labo-
ratory isolate. Interestingly, they remained unresponsive to
this isolate for at least 6 weeks post-presentation. By con-
trast, children in the same age range, from the same area,
with no symptoms of disease, showed signiﬁcantly greater
recognition, whether or not they harboured an asymptom-
atic parasitaemia (t-test P < 0.0005 for all comparisons
between the community samples and the samples from chil-
dren presenting to hospital, both acute presentation and all
follow-up samples).
3.4. Speciﬁcity of antibody responses
In order to assess the speciﬁcity of individual
responses scatter diagrams of paired responses, norma-
lised on a log scale, were plotted (Fig. 4). A distinct posi-
tive correlation between individual responses to each
isolate in turn was observed. This was conﬁrmed by
Spearman’s rank correlation coeﬃcient. Furthermore,
the possibility that these relationships simply reﬂected
an individual’s exposure to malaria infection was
excluded by performing a multiple linear regression
model examining the relationship between responses toeach isolate controlling for age, parasite status at cross-
sectional bleed, and responses to whole schizont extract
as a proxy measure of exposure (Supplementary Table
S2). In addition, again using a multiple linear regression
model, there was no relationship between responses to
schizont extract and individual responses to each isolate
in turn, further strengthening the premise that exposure
alone did not account for the inter-isolate correlations
observed (Supplementary Table S3).
4. Discussion
While it is accepted that children develop ‘protective’
antibodies speciﬁc to the infecting isolate following infec-
tion (Bull et al., 1998), it is not clear how relatively cross-
reactive antibodies or responses directed against less immu-
nogenic conserved targets on the infected erythrocyte sur-
face are involved in protective immunity.
Previously, associations between antibody responses to
isolates not immediately involved in an episode of clini-
cal malaria and subsequent protection have been conﬂict-
ing (Bull et al., 1998, 2002; Giha et al., 2000; Dodoo et
al., 2001). In the Gambia, the best predictor of protec-
tion in children was antibodies directed against a ran-
domly selected clinical isolate (Marsh et al., 1989),
while in Kenya the ability of sera to agglutinate a ran-
domly selected isolate was not associated with protection
(Bull et al., 1998, 2002). In Sudan, antibodies directed
against an isolate from Ghana were associated with pro-
tection while antibodies to six Sudanese isolates were
not. Similarly, in Ghana responses to a Sudanese isolate
and to a Ghanaian isolate demonstrated an association
with protection but responses to another Ghanaian iso-
late did not (Giha et al., 2000; Dodoo et al., 2001).
These data suggest that responses to some isolates but
not others are associated with protection.
We have shown that failure to mount an antibody
response against the surface of erythrocytes infected with
three laboratory parasite lines, including two phenotypes
of a genetically identical isolate, A4 and the reference line
3D7 as well as a locally obtained clinical isolate, was asso-
ciated with susceptibility to clinical malaria in children with
an asymptomatic parasitaemia. The lack of antibody
response in children of the same age, from the same area,
presenting as a case of acute clinical malaria to hospital,
and thus by deﬁnition susceptible, supports this claim. It
is interesting that up to 6 weeks following successful treat-
ment this group of children did not make a response com-
parable with those children from the community who were
well at the time of serum sampling, thus supporting the
possibility that the inability to mount an antibody response
in the presence of parasites may be associated with
susceptibility.
This increased susceptibility amongst those harbouring
parasites but without a concomitant antibody response
might reﬂect a poor inherent ability to respond appropri-
ately in the presence of challenge, as has been suggested
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Fig. 2. Kaplan–Meier survival curves according to antibody and parasite status. Graphs show the proportion of individuals remaining free from clinical
malaria over time (days). Individuals are categorised according to whether they scored positive for antibody recognition of each parasite line in turn
(dashed lines) or negative (solid lines)and whether or not they had microscopically detectable parasites at the time of the cross-sectional bleed. (A) and (B)
Antibody responses measured against A4U; (C) and (D) antibody responses measured against A4 40-cycle; (E) and (F) antibody responses measured
against 3D7; and (G) and (H) antibody responses measured against the clinical isolate P1. **P < 0.005 (logrank);*P < 0.05 (logrank); ns not signiﬁcant.
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2002; Kinyanjui et al., 2003). These particular children
were also more susceptible to multiple infections withinthe follow-up period, further strengthening the likelihood
that, functionally, they represent a true group of
susceptibles.
Table 3
Association of anti-erythrocyte surface antibodies and parasitaemia with protection from clinical malaria
Groupa
ab+ pf+ ab+ pf ab pf+ ab pf
Responses against A4U
n 84 65 33 90
% with malariab 22.62 20 54.5 15.6
OR (95% CI)c 1.67 (0.60–4.63) 1.35 (0.48–3.78) 3.78 (1.21–11.8) 1
P-value 0.325 0.567 0.022 na
Responses against A4 40-cycle
n 39 22 16 63
% with malariab 30.8 45.5 62.5 23.8
OR (95% CI)c 1.55 (0.55–4.34) 2.88 (0.94–8.82) 5.35 (1.66–17.2) 1
P-value 0.402 0.064 0.005 na
Responses against 3D7
n 42 31 13 54
% with malariab 30.9 38.7 69.2 24.1
OR (95% CI)c 1.43 (0.53-3.91) 2.01 (0.74-5.47) 7.10 (1.87-26.9) 1
P-value 0.479 0.170 0.004 na
Responses against P1 (clinical isolate)
n 20 11 35 74
% with malariab 30 54.5 45.7 25.7
OR (95% CI)c 1.38 (0.42–5.97) 3.72 (0.98–14.1) 2.53 (1.07–5.97) 1
P-value 0.587 0.053 0.035 na
a Individuals were stratiﬁed according to whether they were antibody-positive (ab+), scored as corrected mean ﬂuorescence intensity (MFI) greater than
the mean plus 3 SD of the MFI of 20 non-exposed donors, or negative (ab) and parasite-positive (pf+) or -negative (pf) (detected by microscopy) at the
time of the cross-sectional survey.
b Malaria deﬁned as at least one episode of fever >37.5 C plus parasitaemia >2500/ll if aged greater than 1 year and fever >37.5 C plus any
parasitaemia if aged less than 1 year.
c Odds ratio (OR) of becoming a subsequent case of malaria during the 6 month follow-up, obtained from a multiple logistic regression controlling for
age (categorised as a factor of 6 month duration) and exposure (estimated from responses to whole schizont extract) and excluding the ﬁrst 30 days of
follow-up.
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Fig. 3. Antibody responses to Plasmodium falciparum isolate A4U amongst children presenting to hospital with P. falciparum malaria and during follow-
up. Shown are the median plus interquartile range of the log transformed mean ﬂuorescence intensity (MFI) for responses to A4U amongst 39 children
(mean age 29.5 months) resident in Kiliﬁ District from sera taken at acute presentation (acute) and then at 1, 2, 3 and 6 weeks follow-up. The median and
interquartile ranges of the log transformed MFI from asymptomatic parasite-positive children (mean age 29.01 months) and parasite-negative children
(mean age 28.96 months) from the same area are shown for comparison. The horizontal line represents the log transformed MFI obtained from 20 non-
malaria-exposed UK donors plus 3 SD.
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against clinical malaria is associated with the ability to
maintain chronic asymptomatic infections (Marsh, 1992;
Smith et al., 1993). Chronic infections may predispose achild to a wide range of variant epitopes thus inducing
acquisition of a broad repertoire of antibodies. This is sup-
ported by modelling work demonstrating that children able
to recognise multiple heterologous isolates were more likely
Fig. 4. Inter-isolate correlations. Scatter diagrams show correlations of individual responses to pairs of Plasmodium falciparum isolates. All mean
ﬂuorescence intensity (MFI) scores have been log transformed. (A) A4U versus A4 40-cycle; (B) A4U versus 3D7; (C) A4U versus P1; (D) A4 40-cycle
versus P1; (E) A4 40-cycle versus 3D7; (F) P1 versus 3D7. aSpearman’s rank correlation coeﬃcients for each pair of comparisons. Shown are the
coeﬃcients and the signiﬁcance values.
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2004). It may be that the presence of parasites at the time
of serum sampling reveals important, short-lived cross-reactive responses and as such allows measurement of the
breadth of a child’s antibody repertoire. Interestingly the
observation of enhanced anti-erythrocyte surface antibody
C.L. Mackintosh et al. / International Journal for Parasitology 38 (2008) 1445–1454 1453responses in children with an asymptomatic P. falciparum
infection, present in many studies (Iqbal et al., 1993; Giha
et al., 1999a,b; Bull et al., 2002; Ofori et al., 2002; Osier et
al., 2007), and true in this study, was absent in those chil-
dren who subsequently became a case of malaria. This
observation lends support to the premise that the kinetics
and eﬀectiveness of the anti-erythrocyte antibody response
may be altered in those children who demonstrate suscep-
tibility to clinical malaria.
Of course, the importance of chronic infection in the
development of anti-malaria immunity is at odds with the
observation in this study that being parasitaemic per se
was associated overall with an increased susceptibility to
mild clinical malaria. This should be interpreted with cau-
tion as it is not an invariable ﬁnding and previous surveys
in this area have shown no association between asymptom-
atic parasite carriage at the end of a dry season and protec-
tion from, or susceptibility to, severe malarial disease (Bull
et al., 2002). It is not clear if these contrasting results reﬂect
diﬀerent methodologies, diﬀerent outcome measures of
clinical malaria or are due to diﬀerent levels of exposure
amongst the individuals studied. Perhaps most impor-
tantly, this apparent susceptibility among parasite-positive
individuals can be accounted for almost entirely by the
increased incidence of clinical malaria among those who
did not mount a concomitant antibody response to any
of the parasite lines or isolates tested.
The lack of any association between the presence of
anti-erythrocyte surface antibodies and protection from
clinical malaria among children without the presence of
an asymptomatic microscopically detectable parasitaemia
is interesting. It is likely that these antibody responses are
short-lived (Ofori et al., 2002; Kinyanjui et al., 2003) and
thus the presence of antibodies in the absence of parasites
may simply reﬂect a recently treated acute infection and
may be a marker of increased susceptibility to clinical
malaria. Although an individual’s prior experience of
malaria was taken into account as far as possible by includ-
ing responses to schizont extract as a variable in the anal-
ysis and by excluding the ﬁrst 30 days of follow-up, it may
be that these measures are not comprehensive enough. Fur-
thermore, in those children without parasites at the time of
sampling, it is diﬃcult to distinguish those who would
make an adequate and broad antibody response if chal-
lenged from those genuinely unable to. This issue has
become apparent in several recent studies in which analysis
of antibody responses within the whole population demon-
strated no protective eﬀect but when parasite-positive indi-
viduals were analysed separately, a clear protective eﬀect
was shown (Kinyanjui et al., 2004b; Polley et al., 2004;
Osier et al., 2007).
The apparent lack of isolate speciﬁcity of this important
antibody response, unlike that acquired following an epi-
sode of disease (Bull et al., 1998) suggests that the antigenic
targets on the surface of the infected erythrocyte may be
relatively conserved. This is supported by the fact that indi-
vidual responses to each isolate remained highly correlated,even after allowing for exposure as reﬂected by total anti-
schizont response. Whilst this may be expected for compar-
isons made between A4U and A4 40-cycle, if immune selec-
tion results in structuring of var genes into discrete
antigenic groups (Gupta and Anderson, 1999), it was not
expected between the A4 isolates and either 3D7 or the
clinical isolate P1.
The biological function of such an antibody response
remains highly speculative. There are a number of mecha-
nisms through which antibody directed at the infected
erythrocyte surface could mediate protection. While it is
known that sera from individuals resident in malaria ende-
mic areas are able to disrupt cytoadherence to various cell-
lines in vitro (Udeinya et al., 1983; Singh et al., 1988; Bee-
son et al., 2004), the relationship of antibodies able to
block cytoadherence and protection from clinical disease
remains unknown. It is also possible that antibody binding
directly to the erythrocyte surface could facilitate parasite
clearance through opsonisation and phagocytosis. Again
it is clear that sera from individuals in endemic areas have
opsonophagocytic activity (Tebo et al., 2002) but there has
been no conﬁrmation of any relationship between opsono-
phagocytic activity and protection from disease in vivo
(Marsh et al., 1989).
Identifying both the target for this response and its bio-
logical eﬀector mechanism are of considerable importance
both for vaccine development and improved understanding
of the acquisition of immunity in children in malaria ende-
mic areas.
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